Brief: Gri Bio (Nasdaq Gri) Announces Board Of Director Appointments Adding Leadership And Expertise Spanning A Combined 75 Years In Both Public And Private Sectors In The Life Sciences Industry
24/04/2023 13:36
April 24 (Reuters) - GRI Bio Inc GRI.O :
* GRI BIO (NASDAQ: GRI) ANNOUNCES BOARD OF DIRECTOR
APPOINTMENTS
ADDING LEADERSHIP AND EXPERTISE SPANNING A COMBINED 75 YEARS IN
BOTH PUBLIC AND PRIVATE SECTORS IN THE LIFE SCIENCES INDUSTRY
* GRI BIO INC- ANNOUNCED APPOINTMENTS OF DAVID SZEKERES,
ROELOF
RONGEN, MSE, MBA, AND CAMILLA V. SIMPSON, M.SC. TO COMPANY'S
BOARD OF DIRECTORS
* GRI BIO INC- SZEKERES WILL SERVE AS CHAIRMAN OF BOARD
Source text for Eikon: ID:nGNX9dWtwk
Further company coverage: GRI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GRI Bio
See all newsGRI Bio Inc reports results for the quarter ended June 30 - Earnings Summary
GRI Bio Inc expected to post a loss of $1.19 a share - Earnings Preview
Brief: Gri Bio Secures FDA Orphan Drug Designation For Gri-0621 (Tazarotene) In Idiopathic Pulmonary Fibrosis
GRI Bio Q1 net loss narrows on lower R&D expenses
GRI Bio raises $14.5 mln to fund operations into Q1 2027